https://www.indivior.com/latest/media-kit
Media Kit | Indivior
media kitindivior
https://www.clinicaltrialsarena.com/news/newsindivior-reports-positive-topline-phase-iii-trial-results-of-rbp-6000-to-treat-opioid-use-disorder-4981013/
Indivior reports positive topline Phase III trial results of RBP-6000 to treat opioid use disorder...
Aug 17, 2016 - US-based pharmaceutical company Indivior has reported positive topline results from its pivotal Phase III clinical trial of RBP-6000 for opioid use disorder.
https://opiant.com/en/media/press-releases/indivior-provides-preliminary-fy-2020-financial-results
Indivior | Indivior Provides Preliminary FY 2020 Financial Results Ahead of Guidance
financial resultsindiviorprovidespreliminaryfy
https://opiant.com/en/media/press-releases/indivior-announces-first-half-and-second-quarter-2020-results
Indivior | Indivior Announces First Half and Second Quarter 2020 Results
first halfsecond quarterindiviorannouncesresults
https://opiant.com/en/media/press-releases/indivior-announces-fy-2019-financial-results
Indivior | Indivior Announces FY 2019 Financial Results
indiviorannouncesfyfinancialresults
https://www.indivior.com/latest/category/financial-news/2025/indivior-reports-third-quarter-2025-financial-results-and-host-webcast
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th | Indivior
Third Quarter 2025 Financial Results and Host Webcast on October 30th
https://opiant.com/en/investors/shareholder-information/shareholder-meetings
Indivior | Shareholder Meetings
indiviorshareholdermeetings
https://ch.marketscreener.com/kurs/aktie/INDIVIOR-PHARMACEUTICALS--19344116/derivatives-knock-out/
Indivior Pharmaceuticals, Inc.: Turbos CALL PUT | A42086 | US45579U1097 | MarketScreener Schweiz
Indivior Pharmaceuticals, Inc.: Liste der Turbos Call und Put Aktie Indivior Pharmaceuticals, Inc. | A42086 | London S.E.
indiviorpharmaceuticalsincturboscall
https://www.indivior.com/latest/category/financial-news/2018/indivior-prepays-debt
Indivior | Indivior Prepays Debt | Indivior
indiviordebt
https://www.medtruth.com/articles/news/suboxone-monopoly-suit-settled-by-indivior/
Suboxone Monopoly Suit Settled By Indivior | MedTruth - Prescription Drug & Medical Device Safety |...
According to the lawsuit, Indivior undertook a series of actions that ensured that the company could maintain a monopoly of their drug Suboxone.
https://opiant.com/en/media/press-releases/result-of-phase-1-trial-of-rbp-6300-buprenorphine-hemiadipate
Indivior | Result of Phase 1 trial of RBP-6300 Buprenorphine Hemiadipate
indiviorresultphasetrialrbp
https://opiant.com/en/media/press-releases/Court%20Provides%20Final%20Approval%20of%20Settlement%20with%20Direct%20Purchaser%20Class%20in%20the%20Multidistrict%20Antitrust%20Litigation%3B%20Final-Court-Approval-Concludes-the-Antitrust-Multidistrict-Litigation
Indivior | Court Provides Final Approval of Settlement with Direct Purchaser Class in the...
https://www.indivior.com/latest/category/financial-news/2018/indivior-to-announce-and-present-half-year-2018-results
Indivior | Indivior to Announce and Present Half Year 2018 Results on July 25th | Indivior
to announce
https://opiant.com/en/media/press-releases/for-mental-health-awareness-month-indivior-offers-hope-for-opioid-use-disorder-recovery
Indivior | For Mental Health Awareness Month, Indivior Offers Hope for Opioid Use Disorder Recovery
mental health awareness monthopioid use disorder
https://www.indivior.com/latest/category/financial-news/2022/indivior-fy-2021-results
Indivior | Indivior Announces Q4 / FY 2021 Financial Results | Indivior
indiviorannouncesfyfinancialresults
https://ro.bulios.com/ticker/IZQVF
Indivior PLC (IZQVF) Stock | IZQVF Stock Price & Analysis - Bulios
Get the latest news and market analysis for Indivior PLC (IZQVF). Stay up-to-date on IZQVF Stock price and share price with Bulios. Explore our IZQVF Stock...
stock price analysisindiviorplc
https://moneyweek.com/investments/Indivior-shares-plunge
Indivior shares plunge | MoneyWeek
Jul 12, 2024 - Indivior shares dip as its key treatments disappoint the market. What happens next?
indiviorsharesplungemoneyweek
https://ch.marketscreener.com/kurs/aktie/INDIVIOR-PHARMACEUTICALS--19344116/
Indivior Pharmaceuticals, Inc. Aktie (A42086) - Kurs London S.E. - MarketScreener Schweiz
Indivior Pharmaceuticals, Inc.: Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen Aktie Indivior Pharmaceuticals, Inc. | A42086 |...
s eindiviorpharmaceuticalsincaktie